-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GkXg0DgVSumM0ch8zbqMGXSrd0IP4sIe+k1V2A1NGkK7a61gTkRaDfMgHLpJTmc6 dCzEEsAAPQeXx7SKyRE1Fw== 0001299933-05-000365.txt : 20050126 0001299933-05-000365.hdr.sgml : 20050126 20050126164145 ACCESSION NUMBER: 0001299933-05-000365 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20050121 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20050126 DATE AS OF CHANGE: 20050126 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GUILFORD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000918066 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521841960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-23736 FILM NUMBER: 05550533 BUSINESS ADDRESS: STREET 1: 6611 TRIBUTARY ST CITY: BALTIMORE STATE: MD ZIP: 21224 BUSINESS PHONE: 4106316300 8-K 1 htm_2799.htm LIVE FILING Guilford Pharmaceuticals Inc. (Form: 8-K)  

 


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     
Date of Report (Date of Earliest Event Reported):   January 21, 2005

Guilford Pharmaceuticals Inc.
__________________________________________
(Exact name of registrant as specified in its charter)

     
Delaware 000-23736 52-1841960
_____________________
(State or other jurisdiction
_____________
(Commission
______________
(I.R.S. Employer
of incorporation) File Number) Identification No.)
      
6611 Tributary Street, Baltimore, Maryland   21224
_________________________________
(Address of principal executive offices)
  ___________
(Zip Code)
     
Registrant’s telephone number, including area code:   410-631-6300

Not Applicable
______________________________________________
Former name or former address, if changed since last report

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 1.01. Entry into a Material Definitive Agreement.

On January 21, 2005, the Compensation Committee of the Board of Directors of Guilford Pharmaceuticals Inc. (the "Company") approved terms and conditions under which the Company would grant restricted stock units ("RSUs") to employees and officers of the Company as part of the Company’s long term incentive compensation program. These RSUs will be granted under the Company's 2002 Stock Award and Incentive Plan (the "Plan"), and shall vest as to 25% of the RSU grant on the first anniversary of the date of grant and thereafter in six semi-annual installments over the next three years.

The RSUs are subject to the terms and conditions of the Plan as well as other customary terms and conditions set forth in an Employee Stock Unit Agreement (the "Agreement") to be executed by each recipient of RSUs. The foregoing summary of the terms of the RSUs is subject to, and qualified in its entirety by, the terms of the Plan and of the Agreement, a form of which is attached hereto as Exhibit 10.1 and which i s incorporated herein by reference.





Item 9.01. Financial Statements and Exhibits.

(c) Exhibits

10.1 Form of Employee Stock Unit Agreement






SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Guilford Pharmaceuticals Inc.
          
January 26, 2005   By:   Asher M. Rubin
       
        Name: Asher M. Rubin
        Title: Senior Vice President, General Counsel and Secretary


Exhibit Index


     
Exhibit No.   Description

 
10.1
  Form of Employee Stock Unit Agreement
EX-10.1 2 exhibit1.htm EX-10.1 EX-10.1

GUILFORD PHARMACEUTICALS INC.
2002 STOCK AWARD AND INCENTIVE PLAN

EMPLOYEE STOCK UNIT AGREEMENT

     
Stock Unit Transferability
  This grant is an award of stock
units in the number of units set
forth on the cover sheet, subject
to the vesting conditions
described below (“Stock Units”).
Your Stock Units may not be
transferred, assigned, pledged or
hypothecated, whether by
operation of law or otherwise,
nor may the Stock Units be made
subject to execution, attachment
or similar process.
 
   
 
   
 
   
Vesting
  Your Stock Unit grant shall vest
according to the following
schedule; provided that, you
remain in Service on the relevant
vesting dates. If your Service
terminates for any reason, you
will forfeit any Stock Units in
which you have not yet become
vested:
                 
   Vesting Date
  Vesting Percentage
   First Anniversary of Date of Grant
    25 %
   Every six months thereafter
    12.5 %
Your Stock Unit shall be 100% vested upon the occurrence of a Corporate Transaction.
     
Delivery of Stock
Pursuant to Units
  A certificate for the shares of Stock
represented by your Stock Unit Agreement
shall be delivered to you, or to your
eligible beneficiary on each vesting date.
 
   
 
   
 
   
 
  Notwithstanding the preceding paragraph:
 
   
 
  —If the shares relating to the vested
Stock Units would otherwise be delivered
during a period in which you are (i)
subject to a lock-up agreement restricting
your ability to sell shares of Stock in the
open market or (ii) restricted from selling
shares of Stock in the open market because
you are not then eligible to sell under the
Company’s insider trading or similar plan
as then in effect (whether because a
trading window is not open or you are
otherwise restricted from trading),
delivery of the shares related to the
vested Stock Units will be delayed until no
earlier than the first date on which you
are no longer prohibited from selling
shares of Stock due to a lock-up agreement
or insider trading plan restriction.
 
   
Withholding Taxes
  You agree, as a condition of this grant,
that you will make acceptable arrangements
to pay any withholding or other taxes that
may be due as a result of vesting in Stock
Units or your acquisition of Stock under
this grant. In the event that the Company
determines that any federal, state, local
or foreign tax or withholding payment is
required relating to this grant, the
Company will have the right to: (i) require
that you arrange such payments to the
Company, (ii) withhold such amounts from
other payments due to you from the Company
or any Affiliate, or (iii) cause an
immediate forfeiture of shares of Stock
subject to the Stock Units granted pursuant
to this Agreement in an amount equal to the
withholding or other taxes due.
 
   
Retention Rights
  This Agreement does not give you the right
to be retained or employed by the Company
(or any Affiliates) in any capacity.
 
   
Shareholder Rights
  You do not have any of the rights of a
shareholder with respect to the Stock Units
unless and until the Stock relating to the
Stock Units has been delivered to you. You
will, however, be entitled to receive, upon
the Company’s payment of a cash dividend on
outstanding Stock, a cash payment for each
Stock Unit that you hold as of the record
date for such dividend equal to the
per-share dividend paid on the Stock.
 
   
Adjustments
  In the event of a stock split, a stock
dividend or a similar change in the Company
stock, the number of Stock Units covered by
this grant will be adjusted (and rounded
down to the nearest whole number) in
accordance with the terms of the Plan.
 
   
Applicable Law
  This Agreement will be interpreted and
enforced under the laws of the State of
Maryland, other than any conflicts or
choice of law rule or principle that might
otherwise refer construction or
interpretation of this Agreement to the
substantive law of another jurisdiction.
 
   
Consent to Electronic
Delivery
  The Company may choose to deliver certain
statutory materials relating to the Plan in
electronic form. By accepting this grant
you agree that the Company may deliver the
Plan prospectus and the Company’s annual
report to you in an electronic format. If
at any time you would prefer to receive
paper copies of these documents, as you are
entitled to receive, the Company would be
pleased to provide copies. Please contact
the Corporate Secretary to request paper
copies of these documents.
 
   
The Plan
  The text of the Plan is incorporated in
this Agreement by reference. This
Agreement and the Plan constitute the
entire understanding between you and the
Company regarding this grant of Stock
Units. Any prior agreements, commitments
or negotiations concerning this grant are
superseded. The Plan will control in the
event any provision of this Agreement
should appear to be inconsistent with the
terms of the Plan.
 
   

-----END PRIVACY-ENHANCED MESSAGE-----